Durability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined
Among those receiving two doses, peak vaccine efficacy against symptomatic COVID-19 estimated to be 94.1 percent at 120 days after first dose
Text Messaging Intervention Does Not Improve COVID-19 Vaccine Uptake
No increase in vaccine uptake seen for individuals receiving text message versus phone calls or for behaviorally informed message content
Hospital Interns Spend Only 13.4 Percent of Time in Patient Rooms
Real-time locating systems may be used to improve the training experience, authors say
Monkeypox Cases Rising Slowly in the U.S., CDC Says
No deaths have been reported and no community transmission of monkeypox has yet been detected in any U.S. cities
Half of Hospitals Have Implemented No Price Transparency
Only 5.7 percent of hospitals meet both requirements -- a machine-readable file for required price types and an accessible display for at least 300 shoppable items
One in Nine May Get Delayed Large Local Reaction After Moderna Vaccine
Higher risk seen among women and among individuals aged 30 to 69 years
COVID-19 Testing Requirement Lifted for Travelers Flying to the U.S.
CDC has determined the regulation is no longer necessary, but will reevaluate the need every 90 days
Millions of COVID-19 Shots Ready for Children Under 5: White House
Children under 5 are the only age group in the United States not yet eligible for COVID-19 shots
In Utero SARS-CoV-2 Exposure Tied to Neurodevelopmental Sequelae
Maternal SARS-CoV-2 positivity during pregnancy linked to greater rate of neurodevelopmental diagnoses in offspring within first year of life
Moderna Says Updated Vaccine Tackles Omicron
Booster dose combining original vaccine with one specifically aimed at omicron led to 1.75 times more neutralizing antibodies
